Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of -717.37% is 69% above its 1-year average of -2309.47%, near the high end of its 1-year range (-11547.37%–0.00%).
68.94% above its 12-month average of -2309.47%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
GROSS MARGIN
-717.37%
GROSS MARGIN AVG TTM
-2309.47%
GROSS MARGIN AVG 3Y
0.00%
GROSS MARGIN AVG 5Y
0.00%
GROSS MARGIN AVG 10Y
0.00%
GROSS MARGIN AVG 15Y
N/A
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+68.94%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
39.32%
median of 673 covered companies
CURRENT VS SECTOR MEDIAN
-1924.44%
vs the sector median at left
aTyr Pharma, Inc.
Market Cap
$28.71M
Gross Margin
-717.37%
TTM Avg
-2309.47%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$29.73M
Gross Margin
-37.01%
TTM Avg
-40.36%
3Y Avg
-31.14%
5Y Avg
-18.20%
Market Cap
$27.55M
Gross Margin
-423.83%
TTM Avg
-211.91%
3Y Avg
-105.96%
5Y Avg
-82.75%
Market Cap
$30.31M
Gross Margin
-3398.93%
TTM Avg
-1699.46%
3Y Avg
-849.73%
5Y Avg
-566.49%
Market Cap
$26.53M
Gross Margin
62.59%
TTM Avg
69.78%
3Y Avg
74.14%
5Y Avg
76.12%
Market Cap
$31.22M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| aTyr Pharma, Inc. (ATYR) | $28.71M | -717.37% | -2309.47% | 0.00% | 0.00% |
| OneMedNet Corporation (ONMD)vs › | $29.73M | -37.01% | -40.36% | -31.14% | -18.20% |
| Seres Therapeutics, Inc. (MCRB)vs › | $27.55M | -423.83% | -211.91% | -105.96% | -82.75% |
| CervoMed Inc. (CRVO)vs › | $29.91M | 0.00% | 0.00% | 0.00% | 0.00% |
| InspireMD, Inc. (NSPR)vs › | $27.33M | 29.50% | 25.49% | 25.43% | 20.30% |
| GridAI Technologies Corp. (GRDX)vs › | $30.31M | -3398.93% | -1699.46% | -849.73% | -566.49% |
| MDxHealth S.A. (MDXH)vs › | $30.73M | 59.74% | 60.48% | 58.85% | 54.42% |
| iTonic Holdings Ltd. (ITOC)vs › | $26.53M | 62.59% | 69.78% | 74.14% | 76.12% |
| MIRA Pharmaceuticals, Inc. (MIRA)vs › | $31.22M | 0.00% | 0.00% | 0.00% | 0.00% |
| BeyondSpring Inc. (BYSI)vs › | $31.26M | 0.00% | 0.00% | 25.00% | 50.00% |
Gross Margin
-717.4%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | -11547.37% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 100.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | -181.30% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 93.29% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 100.00% |
| 2020-09-30 | 100.00% |
| 2020-06-30 | 100.00% |
| 2020-03-31 | 100.00% |
| 2019-12-31 | 100.00% |
| 2019-09-30 | 100.00% |
| 2019-06-30 | 100.00% |
| 2019-03-31 | 0.00% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | 0.00% |
| 2016-12-31 | 0.00% |
| 2016-09-30 | 0.00% |
| 2016-06-30 | 0.00% |
| 2016-03-31 | 0.00% |
| 2015-12-31 | 0.00% |
| 2015-09-30 | 0.00% |
| 2015-06-30 | 0.00% |
| 2015-03-31 | 0.00% |
| 2014-12-31 | 0.00% |
| 2014-09-30 | 0.00% |
| 2014-06-30 | 0.00% |
| 2014-03-31 | 0.00% |
| 2013-12-31 | 0.00% |
